Sugi Predict

Sugi Predict / Compounds / SCHEMBL30839888

SCHEMBL30839888

SCHEMBL30839888

CC[C@H](C)[C@H](NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](C)N)C(C)C)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@@H](CS)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ APLNR P35414 1/20 0.46
▸ GLP1R P43220 17/20 0.42
▸ C5AR1 P21730 1/20 0.41
▸ KEAP1 Q14145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30839892 0.93 GLP1R (0.45) APLNRGLP1RC5AR1KEAP1
SCHEMBL29484316 0.88 NPY4R (0.42) APLNR
SCHEMBL30455424 0.87 GLP1R (0.50) GLP1RKEAP1
SCHEMBL30811634 0.86 GLP1R (0.45) GLP1RC5AR1KEAP1
SCHEMBL31555933 0.86 GLP1R (0.44) APLNRGLP1RKEAP1
SCHEMBL31555932 0.86 GLP1R (0.44) APLNRGLP1RKEAP1
SCHEMBL29962070 0.86 GLP1R (0.52) GLP1RC5AR1
SCHEMBL30823264 0.85 APLNR (0.50) APLNRGLP1RC5AR1KEAP1
SCHEMBL30216223 0.84 APLNR (0.41) APLNR
SCHEMBL31353029 0.84 GLP1R (0.52) GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250082716-A1 REPRESSED ANG 1-7 IN COVID-19 IS INVERSELY ASSOCIATED WITH INFLAMMATION AND COAGULATION UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2025-03-13 — — US claimed
WO-2024054198-A1 REPRESSED ANG 1-7 IN COVID-19 IS INVERSELY ASSOCIATED WITH INFLAMMATION AND COAGULATION UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2024-03-14 — — WO claimed
US-20250082716-A1 REPRESSED ANG 1-7 IN COVID-19 IS INVERSELY ASSOCIATED WITH INFLAMMATION AND COAGULATION UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2025-03-13 — — US disclosed
WO-2024054198-A1 REPRESSED ANG 1-7 IN COVID-19 IS INVERSELY ASSOCIATED WITH INFLAMMATION AND COAGULATION UNIVERSITY OF VIRGINIA PATENT FOUNDATION (US) 2024-03-14 — — WO disclosed
Send feedback